R. Ingraham

发表

The phospholipase A2 of human spermatozoa; purification and partial sequence.

J. Chafouleas, J. Langlais, R. Ingraham, 1992, Biochemical and biophysical research communications.

Membrane proximal cleavage of L-selectin: identification of the cleavage site and a 6-kD transmembrane peptide fragment of L-selectin

T. Kishimoto, R. Ingraham, J. Kahn, 1994, The Journal of cell biology.

Catalysis and Function of the p38α·MK2a Signaling Complex

C. Pargellis, B. Werneburg, S. Lukas, 2004 .

Proteolytic processing of the cardioviral P2 region: primary 2A/2B cleavage in clone-derived precursors.

G. Parks, D. Hall, A. Palmenberg, 1992, Virology.

Regulation of L-selectin expression by membrane proximal proteolysis.

R. Rothlein, T. Kishimoto, R. Ingraham, 1995, Agents and actions. Supplements.

High-performance liquid chromatography and photoaffinity crosslinking to explore the binding environment of nevirapine to reverse transcriptase of human immunodeficiency virus type-1

P. Grob, R. Ingraham, S. Kapadia, 1994 .

Nonnucleoside inhibitors of HIV-1 reverse transcriptase: nevirapine as a prototype drug.

P. Grob, R. Ingraham, J. Wu, 1992, AIDS research and human retroviruses.

Assembly of major histocompatibility complex (MHC) class II transcription factors: association and promoter recognition of RFX proteins.

R. Ingraham, C. A. Grygon, R. Kroe, 2004, Biochemistry.

Substituted pyrazoles as novel sEH antagonist: investigation of key binding interactions within the catalytic domain.

J. Proudfoot, U. Patel, Rajiv Sharma, 2010, Bioorganic & medicinal chemistry letters.

High-affinity interactions of tumor necrosis factor receptor-associated factors (TRAFs) and CD40 require TRAF trimerization and CD40 multimerization.

T. Alber, M. Kehry, R. Ingraham, 1999, Biochemistry.

Characterization of the binding site for nevirapine (BI-RG-587), a nonnucleoside inhibitor of human immunodeficiency virus type-1 reverse transcriptase.

S. Rogers, C. Pargellis, R. Ingraham, 1991, The Journal of biological chemistry.

Soluble epoxide hydrolase inhibitors and their potential for treatment of multiple pathologic conditions.

R. Ingraham, R. Gless, H. Lo, 2011, Current medicinal chemistry.

Solvent isotope effects in intramolecular catalysis: Acyl transfer reactions of 4-nitrophenyl 5-nitrosalicylate in aqueous tris buffer

R. Ingraham, E. L. Kelley, R. Gandour, 1979 .

Binary interactions of troponin subunits.

R. Ingraham, C. Swenson, 1984, The Journal of biological chemistry.

Studies on the regulatory complex of rabbit skeletal muscle: Contributions of troponin subunits and tropomyosin in the presence and absence of Mg2+ to the acto-S1 ATPase activity

R. Hodges, R. Ingraham, J. Eyk, 1986 .

Dissociation of the effect of caldesmon on the ATPase activity and on the binding of smooth heavy meromyosin to actin by partial digestion of caldesmon.

R. Ingraham, J. Chalovich, L. Velaz, 1990, The Journal of biological chemistry.

Comparative purification of recombinant HIV-1 and HIV-2 reverse transcriptase: preparation of heterodimeric enzyme devoid of unprocessed gene product.

S. Rogers, R. Ingraham, G. Caviness, 1992, Protein expression and purification.

Effects of Ca2+ and subunit interactions on surface accessibility of cysteine residues in cardiac troponin.

R. Hodges, R. Ingraham, 1988, Biochemistry.

Interaction of troponin and tropomyosin: spectroscopic and calorimetric studies.

R. Ingraham, C. Swenson, 1985, Biochemistry.

Calmodulin and troponin C: a comparative study of the interaction of mastoparan and troponin I inhibitory peptide [104-115].

R. Hodges, C. Kay, J. V. Van Eyk, 1986, Biochemistry.

Stability of the Ca2+-specific and Ca2+-Mg2+ domains of troponin C. Effect of pH.

R. Ingraham, C. Swenson, 1983, European journal of biochemistry.

Understanding the Cellular and Molecular Mechanisms of Physical Activity-Induced Health Benefits.

Claude Bouchard, Mary Evans, Lyndon Joseph, 2015, Cell metabolism.

Compensatory Mechanism for Homeostatic Blood Pressure Regulation in Ephx2 Gene-disrupted Mice*

B. Hammock, J. Newman, C. Morisseau, 2007, Journal of Biological Chemistry.

Determination of receptor-ligand kinetic and equilibrium binding constants using surface plasmon resonance: application to the lck SH2 domain and phosphotyrosyl peptides.

S. Jakes, R. Ingraham, R H Ingraham, 1995, Journal of medicinal chemistry.

Activity of purified biosynthetic proteinase of human immunodeficiency virus on natural substrates and synthetic peptides.

E. Wimmer, H. Kräusslich, P. Pallai, 1989, Proceedings of the National Academy of Sciences of the United States of America.

Denaturation and the effects of temperature on hydrophobic-interaction and reversed-phase high-performance liquid chromatography of proteins

R. Hodges, R. Ingraham, S. Y. Lau, 1985 .

Amino acid substitutions in HIV-1 reverse transcriptase with corresponding residues from HIV-2. Effect on kinetic constants and inhibition by non-nucleoside analogs.

D. Richman, A. Bacolla, R. Ingraham, 1993, The Journal of biological chemistry.

Thermal denaturation: a method to rank slow binding, high-affinity P38alpha MAP kinase inhibitors.

C. Pargellis, J. Regan, G. W. Peet, 2003, Journal of medicinal chemistry.

Catalysis and function of the p38 alpha.MK2a signaling complex.

C. Pargellis, B. Werneburg, S. Lukas, 2004, Biochemistry.

14,15-Dihydroxyeicosatrienoic acid relaxes bovine coronary arteries by activation of K(Ca) channels.

J. Falck, W. Campbell, Pin-Lan Li, 2002, American journal of physiology. Heart and circulatory physiology.

Determination of affinities for lck SH2 binding peptides using a sensitive fluorescence assay: comparison between the pYEEIP and pYQPQP consensus sequences reveals context-dependent binding specificity.

R. Ingraham, C. A. Grygon, C A Grygon, 1996, Biochemistry.

Structural and biochemical analysis of signal transduction by the TRAF family of adapter proteins.

T. Alber, B. Werneburg, M. Kehry, 1999, Cold Spring Harbor symposia on quantitative biology.

Interaction between the SH2 domains of ZAP-70 and the tyrosine-based activation motif 1 sequence of the zeta subunit of the T-cell receptor.

S. Lukas, S. Jakes, R. Ingraham, 1997, Archives of biochemistry and biophysics.

Ligands for the tyrosine kinase p56lck SH2 domain: discovery of potent dipeptide derivatives with monocharged, nonhydrolyzable phosphate replacements.

J. Proudfoot, L. Tong, E. Hickey, 1999, Journal of medicinal chemistry.

Binding affinities of the SH2 domains of ZAP‐70, p56/ck and Shc to the chain ITAMs of the T‐cell receptor determined by surface plasmon resonance

S. Jakes, R. Ingraham, J. Schembri-King, 1996, Journal of leukocyte biology.

Specificity of the polioviral proteinase 3C towards genetically engineered cleavage sites in the viral capsid.

E. Wimmer, C. Mirzayan, R. Ingraham, 1991, The Journal of general virology.

Understanding the Cellular and Molecular Mechanisms of Physical Activity-Induced Health Benefits.

M. Rodgers, W. Kraus, J. Fleg, 2015, Cell metabolism.